Home >
Medicine Info >
Lamivir 300 mg Solution
Loading interface...

Lamivir 300 mg Solution

Manufactured byCipla Ltd.
ContainsLamivudine
Description
Lamivir 300 mg Solution is an antiviral medicine that is used to treat human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections. This medicine is not a cure for HIV. It only prevents the virus from multiplying in your body. Monitoring of liver function and kidney function may be necessary while receiving this medicine based on the clinical condition.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Side effects

Major & minor side effects for Lamivir 300 mg Solution

  • Chills and fever
  • Diarrhea
  • Headache
  • Fatigue
  • Loss of appetite
  • Stuffy nose
  • Muscle pain
  • Heartburn
  • Indigestion
  • Sore throat

Uses of Lamivir 300 mg Solution

What is it prescribed for?

  • HIV infection
  • Chronic Hepatitis B
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time required for this medicine to show its effect is not clinically established.
  • How long do the effects of this medicine last?
    The time until which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to lamivudine, or any other inactive ingredients present along with the formulation.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.
General warnings

Immune reconstitution syndrome

This medicine should be used with caution due to the increased risk of Immune reconstitution syndrome. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Lactic acidosis

This medicine should be used with caution due to the increased risk of Lactic acidosis. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Hepatotoxicity

This medicine should be used with caution in patients with a history of liver disease and active liver disease due to the increased risk of worsening of the patient's condition. Report any unusual symptoms to the doctor immediately. Therapy may need to be discontinued if the patient develops pronounced hepatotoxicity.

Pancreatitis

This medicine may cause pancreatitis. Report any unusual symptoms to the doctor immediately. Therapy may need to be discontinued if the patient develops any signs or symptoms of pancreatitis.

Dosage formulations

The formulations for HIV infection and HBV infection may be different and may contain different doses of the active ingredient. These formulations are not interchangeable. Patients are advised to only use the formulation prescribed by the doctor. Any change in the formulation should be done only under the supervision of a qualified healthcare professional.

Missed Dose

Take/Administer the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Methotrexate

Efavirenz

Disease interactions

Kidney disease

This medicine should be used with extreme caution in patients with kidney diseases due to the increased risk of severe adverse effects. The kidney function should be assessed before initiating the treatment. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Pancreatitis

This medicine may cause pancreatitis in some patients. Report any unusual symptoms to the doctor immediately. Therapy may need to be discontinued if the patient develops any signs or symptoms of pancreatitis.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take/Administer this medicine exactly as instructed by the doctor. Do not take/administer in larger or smaller quantities than recommended. Ensure that proper hygiene measures are adopted. Complete the course of treatment to prevent the spread of the infection. Close monitoring of liver function and kidney function may be necessary while receiving this medicine based on the clinical condition.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine works by stopping the human immunodeficiency virus (HIV) and hepatitis B virus (HBV) from multiplying. This helps in reducing the chances of the development of acquired immunodeficiency syndrome (AIDS) and other HIV-related illnesses.
Legal Status

Approved

Approved

Unknown

Approved

Classification

Category

Nucleoside reverse transcriptase inhibitors (nrtis)

Schedule

Schedule H

Lamivudine - DrugBank [Internet]. Drugbank.ca. 2017 [cited 29 August 2017]. Available from:

https://www.drugbank.ca/drugs/DB00709

Lamivudine: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 29 August 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a696011.html

[Internet]. 2017 [cited 29 August 2017]. Available from:

https://www.medicines.org.uk/emc/product/942/smpc

[Internet]. Accessdata.fda.gov. 2020 [cited 2 January 2020]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020564s37_020596s036lbl.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 16 Jan 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.